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ABSTRACT A technique was developed for studying the nucleation and growth of ﬁbrillar protein aggregates. Fourier trans-
form infrared and attenuated total reﬂection spectroscopy were used to measure changes in the intermolecular b-sheet content
of bovine pancreatic insulin in bulk solution and on model polystyrene (PS) surfaces at pH 1. The kinetics of b-sheet formation
were shown to evolve in two stages. Combined Fourier transform infrared, dynamic light scattering, atomic force microscopy,
and thioﬂavin-T ﬂuorescence measurements conﬁrmed that the ﬁrst stage in the kinetics was related to the formation of
nonﬁbrillar aggregates that have a radius of 13 6 1 nm. The second stage was found to be associated with the growth of insulin
ﬁbrils. The b-sheet kinetics in this second stage were used to determine the nucleation and growth rates of ﬁbrils over a range of
temperatures between 60C and 80C. The nucleation and growth rates were shown to display Arrhenius kinetics, and the
associated energy barriers were extracted for ﬁbrils formed in bulk solution and at PS surfaces. These experiments showed that
ﬁbrils are nucleated more quickly in the presence of hydrophobic PS surfaces but that the corresponding ﬁbril growth rates
decrease. These observations are interpreted in terms of the differences in the attempt frequencies and energy barriers as-
sociated with the nucleation and growth of ﬁbrils. They are also discussed in the context of differences in protein concentration,
mobility, and conformational and colloidal stability that exist between insulin molecules in bulk solution and those that are
localized at hydrophobic PS interfaces.
INTRODUCTION
The effects of surfaces and interfaces on the misfolding and
subsequent aggregation of proteins are an important consid-
eration in a number of biological and technologically impor-
tant areas. For example the presence of an abundance of
interfaces in vivo has resulted in a number of studies that
were designed to assess the role played by model biological
membranes and synthetic surfaces on the stability and aggre-
gation properties of proteins (1–4). These separate studies
showed that the presence of surfaces and interfaces can have
a profound effect on aggregate development and that the
growth rates and ﬁnal aggregate morphologies are sensitive
to the details of the surface chemistry of an interface (e.g.,
hydrophobicity, charge). However, many of these studies are
semiquantitative in nature, and a more quantitative measure
of the effects of surfaces and interfaces on the stability of pro-
teins remains to be obtained.
Interfacial effects are particularly important for a number
of protein conformational disease–related states that involve
the aggregation of protein molecules into long ﬁbrous struc-
tures called amyloid ﬁbrils. These structures typically com-
prise linear aggregates of smaller protein units (e.g., monomers
and dimers). They have diameters that are comparable to the
dimensions of one or two protein molecules and can be many
micrometers in length. These structures and their precursors
have been linked to a number of diseases such as Alzheimer’s
disease, Huntington’s disease, Parkinson’s disease, type II
diabetes, and Creutzfeldt-Jakob disease (5–8). In each case,
the aggregates that are formed from different proteins have
been found to exhibit very similar morphologies and to con-
tain large amounts of chain-folded intermolecular b-sheet
structures. This has recently led to the conclusion that amy-
loid ﬁbril formation is a generic property of proteins (5–8).
As a result, a signiﬁcant amount of research has been carried
out to try to develop an understanding of the molecular-level
processes that result in their formation. The fact that these
structures are usually formed in the presence of a wide range
of biological interfaces also suggests that developing a
greater knowledge of how protein/surface interactions affect
the formation of these structures could help us to understand
these processes.
Recent developments in the rapidly emerging ﬁeld of
nanotechnology also raise some important questions about
the effects of surfaces and interfaces on the stability and
aggregation properties of proteins and other biological mac-
romolecules (9). Nanoscale materials and particles such as
those being used in novel biosensing applications (10),
immunological assays, and early gene gun–based delivery
methods (11) have surface-to-volume ratios that are up to 108
times larger than bulk samples of the same materials. The
surface-related effects that have already been reported in
studies of protein aggregation (1–3) therefore have important
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implications for the nanotoxicology of a wide range of
materials.
Protein aggregation is also of considerable interest to the
pharmaceutical industry, where maintaining the stability of
proteins at low pH is vital during the production and puri-
ﬁcation of protein-based drugs such as insulin (12–14). The
storage of proteins is also an important factor in determining
the shelf life of these materials. In particular, the effects of
storing and processing proteins such as insulin in different
containers are likely to affect their long-term stability.
In this article we describe an experimental study of
aggregation and amyloid ﬁbril formation in bovine pancre-
atic insulin (BPI) at elevated temperatures and low pH.
Fourier transform infrared (FTIR) spectroscopy and attenu-
ated total reﬂection (ATR) spectroscopy are used to monitor
the aggregation/b-sheet-formation kinetics of this protein in
bulk solution and on model hydrophobic polystyrene (PS)
surfaces. The temperature dependence of the nucleation/lag
times and aggregation rates associated with insulin ﬁbril
formation are used to determine the energy barriers associ-
ated with the nucleation and growth of these structures, re-
spectively. Complementary techniques such as atomic force
microscopy (AFM), dynamic light scattering (DLS), and
thioﬂavin-T ﬂuorescence assays were also used to monitor
the growth of the protein aggregates. To the best of our
knowledge, these experiments represent the ﬁrst quantitative
study of the effects of surfaces and interfaces on the ag-
gregation properties of proteins.
EXPERIMENTAL PROCEDURES
Stock solutions of 0.025M NaCl and 0.1 M HCl (pH 1) were prepared in
preboiled deuterium oxide (D2O, Goss Scientiﬁc, Essex, UK). These
solutions were then sealed in 15-ml sample vials and degassed by being
placed in a water bath at;85C for 1 h. The solutions were then allowed to
cool to room temperature. BPI (Sigma Aldrich, Gillingham, UK, mol wt ¼
5733, catalog No. I5500) was then dissolved in the solutions at a
concentration of 20 mgml1 (;3.5 mM). A single batch of BPI was used
in all the experiments described below because batch-to-batch variations in
the properties of insulin have been reported (15). The resulting protein
solutions were then left at room temperature in sealed vials for a further 24 h
to enable the complete hydrogen-deuterium exchange of labile hydrogens on
the insulin molecules.
Fourier transform infrared spectroscopy
FTIR spectroscopy measurements were collected using a Varian FTS40 Pro
spectrometer equipped with Resolutions Pro 4.0 software. Each averaged
spectrum was collected using a spectral resolution of 4 cm1, and the time
between the collection of the averaged spectra was 15 s. Deuterium oxide
was used as the solvent in these experiments to avoid difﬁculties associated
with the overlap of liquid water peaks with the amide I and amide II regions
of the protein IR spectra. No spectral subtraction was performed on the
infrared spectra. However, the baseline of the spectra tilted during the
experiments as a result of variations in the intensity of the IR light source
used in the spectrometer. This tilting was corrected for by subtracting a
linear baseline, which was calculated using the ﬂat regions of the spectra in
the ranges 850–1100 cm1 and 1750–2100 cm1.
Bulk solution IR spectroscopy measurements were performed over a
range of temperatures from 60C to 80C using an electrically heated liquid
transmission cell with zinc selenide (ZnSe) windows (Specac, Orpington,
UK). One of the ZnSe windows was predrilled with two holes through its
larger faces to allow the cell volume to be exchanged with ﬂuid. Before the
experiments, one side of each ZnSe window was spin coated with a 2 wt %
solution of PS (Mw ¼ 600 kDa, Mw/Mn ¼ 1.09, Polymer Source) in toluene
(spin speed 2500 rpm) and then annealed under vacuum at ;120C to
remove residual solvent. This resulted in the formation of an;200-nm-thick
PS ﬁlm (as measured using atomic force microscopy). This was done to
protect the windows from the acidic solutions used in the experiments.
Acidic solutions are known to dissolve ZnSe, and Zn21 ions have been
shown to promote the onset of ﬁbril formation in some proteins (16).
The two ZnSe windows were then placed together with their PS-coated
surfaces separated by a 75-mm-thick poly (tetraﬂuoroethylene) (PTFE)
spacer. This procedure was used to produce a small cavity with a 75-mm-
thick path length for performing liquid transmission IR studies. The resulting
assembly was then sealed around the edge using a highly viscous solution of
PS in toluene. The windows and spacer were then annealed at ;100C for
2 h to remove residual toluene and to seal the edges of the cell so that it
would not leak when ﬁlled. The window assembly was then placed in the
sample cell and loaded into the sample chamber of the FTIR spectrometer.
Stainless steel tubing was then attached to the sample cell so that the volume
of the cell could be exchanged from outside the FTIR sample chamber. The
chamber was then purged with dry air.
The fully assembled liquid cell was then heated to the desired exper-
imental temperature, which was monitored using a precalibrated t-type ther-
mocouple buried in the metal body of the cell (close to the ZnSe windows).
Deuterium oxide–based stock solution was then injected into the cell. A
background spectrum was collected by averaging 100 individual spectra,
and the stock solution was replaced with an identical solution containing
20 mgml1 of BPI. Immediately after the injection of the protein solution,
spectra were collected with a time resolution of 15 s. In each case 15 spectral
scans were averaged per spectrum. All spectra were then ratioed to the
spectrum obtained from the D2O stock solution.
FTIR spectra of BPI adsorbed at PS surfaces were also collected using an
ATR liquid cell (Specac). The ATR geometry uses the total internal
reﬂection of IR radiation at a ZnSe/solution interface to produce an
evanescent ﬁeld that penetrates ;1 mm into the solution. Because the
intensity of this ﬁeld decays exponentially as a function of distance, the IR
spectra that are obtained using this technique are extremely sensitive to
material that is close to the interface.
Thin ﬁlms (;200 nm) of PS were spin coated onto one side of a ZnSe
ATR crystal using the same experimental parameters used to coat the ZnSe
windows described above. The PS coated crystal was then annealed under
vacuum at ;120C to remove residual solvent and then allowed to cool to
room temperature. The ATR crystal was then loaded into the ATR liquid cell
and heated to the required temperature using a circulating water bath. The
temperature in the cell was monitored using a thermocouple embedded in the
ATR cell top plate that had been precalibrated against the measured
temperature inside the cell. The sample cell was then ﬁlled with the D2O-
based stock solution and allowed to equilibrate before a background
spectrum was collected by averaging 100 individual spectra. The solution
was then replaced with an identical solution containing 20 mgml1 BPI, and
spectra were collected every 15 s (averaging 15 scans per spectrum).
Atomic force microscopy of BPI aggregates
BPI was dissolved in the D2O-based stock solutions at a concentration of
20 mgml1. Bulk solution insulin ﬁbrils were formed by incubating sealed
vials of the resulting protein solution in a water bath at 60C. The vials were
then removed at regular time intervals and placed in an ice bucket to slow
down the ﬁbril growth rates and quench in the structure of the ﬁbrils.
Surface-adsorbed ﬁbrils were prepared on PS-coated single-crystal
silicon wafers (Si, Compart Technology, [100], ;300 mm thick). An
;200-nm-thick PS ﬁlm was spin coated on to the Si wafers from a 2 wt %
solution in toluene and annealed at 120C under vacuum. The resulting PS
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ﬁlms were then submerged (facing downward) in vials containing similar
solutions to those used to form the bulk ﬁbrils and were incubated in a water
bath at 60C. The sealed vials were then removed at regular time intervals
and quenched in a bucket of ice.
In the case of the bulk solution ﬁbrils, a droplet of each protein solution
was transferred onto a clean PS-coated Si wafer and allowed to dry before
being imaged with an Asylum Research MFP-3D AFM. The ﬁbrils formed
on the PS surfaces were simply allowed to dry out before being imaged. All
samples were imaged using tapping-mode AFM.
Dynamic light-scattering studies
The time evolution of the average aggregate size in 20 mgml1 solutions of
BPI in D2O-based stock solutions was studied at a temperature of 60C
using a Malvern Instruments DLS (4700 PCS).
Thioﬂavin-T studies
Thioﬂavin-T (ThT) ﬂuorescence studies were used to monitor the kinetics of
b-sheet formation during aggregation/ﬁbril formation in BPI. Solutions of
BPI (20 mgml1) containing ;2.5 mM ThT were placed on a glass
coverslip inside an ;10-mm-diameter O-ring. A second coverslip was
clamped on top of the O-ring to create a sealed sample cell. The cell was then
placed on top of a home-made heater and mounted on the stage of an
Olympus BX51 optical microscope equipped with ﬂuorescence capabilities
and a DP70 CCD camera and connected to a PC running Image Pro Plus
software (Media Cybernetics). The protein solution was heated to 60C, and
the excited ﬂuorescence measured through a ﬁlter (l  470–490 nm,
U-MNB2, Olympus) using the CCD camera. Optical micrographs of the
solution in the sample cell were then collected at 30-s intervals. The Image
Pro Plus software was then used to determine the average ﬂuorescence
intensity obtained from the optical micrographs as a function of time.
RESULTS AND DISCUSSION
Fig. 1 shows an example of a typical FTIR spectrum of the
amide I and II regions that was obtained using the bulk liquid
transmission cell. Spectra obtained from both the bulk liquid
transmission cell and the ATR cell had similar features.
Minor differences in the spectra were attributed to the wave-
number dependence of the penetration depth of the evanes-
cent ﬁeld in the ATR experiments. The spectra obtained for
the combined amide I and II regions were ﬁtted to ﬁve
Lorentzian peaks (shown as the gray lines in Fig. 1) using a
nonlinear least-squares ﬁtting algorithm. The assignments of
these peaks are given in the inset of Fig. 1. The sum of all
these peaks is shown as the black solid line in the main panel
of Fig. 1. The assignments of the peaks in the amide I region
are consistent with literature reports of the positions of peaks
that correspond to features associated with b-sheet, random
coil, and a-helix (17–19). The two peaks used to represent
the amide II region in our ﬁtting procedure do not have any
speciﬁc assignments and were simply used to describe the
shape of the spectra. The shape of this region did not change
during the course of the FTIR experiments, and these peaks
were found to represent the shape of the amide II region
accurately (see Fig. 1).
The small peak shown at;1525 cm1 in Fig. 1 forms part
of the amide II region. As a result, this small feature was
found to change in proportion to the other peaks in the amide
II region during the FTIR experiments. This peak was not
ﬁtted because it would have involved introducing three
additional parameters into the ﬁtting procedure described
above. The addition of a ﬁtted peak at;1525 cm1 does not
signiﬁcantly affect the heights, positions, or widths of the
other ﬁtted peaks. Because of this, the smaller peak was
ignored to speed up the optimization of the ﬁtting process.
The ﬁtting procedure was performed on all the spectra
collected from each FTIR experiment. The positions of all
but the b-sheet peak (1610–1633 cm1) were constrained to
within 6 2 cm1, and the widths were constrained to within
6 5 cm1. The position of the b-sheet peak was allowed to
vary by 612 cm1 as reports by Nielsen and co-workers
suggest that the position of this peak changes during the
aggregation of insulin (17). The amplitudes of all the peaks
were not constrained and were allowed to vary during the
ﬁtting procedure.
The ﬁtting procedure typically gave an initial value for the
ratio of the areas of the ﬁtted peaks of 7%:54%:39% (b-sheet/
a-helix/random coil). The ﬁnal value of this ratio was typ-
ically found to be 76%:20%:4%. These values are in agree-
ment with results obtained from other studies of insulin
aggregation (17,19,20).
The areas of the peaks obtained from the ﬁtting procedure
were then used to generate plots of the kinetics of b-sheet
growth, similar to those shown in Fig. 2. To decouple the
effects of changes in the b-sheet content of the BPI mole-
cules from effects caused by changing amounts of protein in
the beam path, the area of the b-sheet peak was divided by
the sum of the areas of the two peaks used to ﬁt the amide II
region in the same FTIR spectrum (see Fig. 1). The shape of
the amide II region did not change during the experiments,
indicating that this peak was insensitive to structural changes
FIGURE 1 Infrared spectrum of the amide I and II spectral regions for
bovine pancreatic insulin collected at 60C and pH 1 after incubation for
;100 min. The gray lines show the ﬁve Lorentzian peaks that were used to
ﬁt the data (s). The inset shows a table of the peaks used to ﬁt the data along
with their protein structural assignments (17). The black solid line is the
combined ﬁt to the data and is given by summing the contributions of the
ﬁve separate Lorentzian peaks.
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in the BPI molecules. This result is consistent with the results
obtained by Hiramatsu and Kitagawa (21). The effects of
hydrogen-deuterium (H-D) exchange on changes in the size
and shape of the amide II region can be excluded as the
bending mode of N-D (centered 1445 cm1) and N-H
(centered 1545 cm1) are in very different places and are
easily distinguishable using the FTIR technique. As de-
scribed in the experimental section, the protein was initially
placed in D2O-based stock solutions for 24 h to facilitate the
exchange of hydrogen atoms on the outside of the insulin
molecules. The remaining hydrogen atoms buried in the
center of the protein (14) were observed to undergo H/D
exchange via a shift in the peak at 1545 cm1 to 1445 cm1.
However, in the case of the 60C data, this change occurred
over a period of time corresponding to the time taken to
collect the ﬁrst two FTIR spectra. This indicates that any
residual H-D exchange occurs rapidly even at the lowest
temperatures studied. This is conﬁrmed by the results of
similar studies performed by Dzwolak and co-workers
(22,23). The amide II peak was therefore used as a measure
of the amount of protein in the beam path. Dividing the area
of the b-sheet peak by the area of each spectrum’s amide II
region in this way therefore gives a measure of the extent of
b-sheet formation per unit mass of protein during aggrega-
tion/ﬁbril formation.
As shown in the inset of Fig. 2, the total area of the amide
II peak increases with time during the ATR experiments on
PS surfaces. This increase was attributed to changes in the
amount of insulin at the PS/water interface caused by the
continued adsorption and aggregation of insulin at the PS
surfaces. The area of the amide II peak measured in the bulk
transmission cell experiments did not change appreciably
during the course of the experiments. This is to be expected
because the amount of protein in the IR beam path remains
constant during these experiments.
Fig. 2 shows that the b-sheet kinetics curves obtained
from the bulk transmission and ATR experiments are similar
but not identical. In each case, the b-sheet content of the
protein aggregates was found to display two-stage kinetics.
The initial phase of b-sheet growth rapidly saturated after
;400–700 s. This initial growth stage in the kinetics was
also found to occur on similar timescales in both the ATR
and bulk transmission studies.
DLS and ThT ﬂuorescence studies performed at 60C
revealed that this ﬁrst stage in the b-sheet kinetics was
produced by the rapid formation of protein aggregates with
an average radius of 13 6 1 nm (see Fig. 3). The cor-
respondence among the features observed in the FTIR data,
the dynamic light-scattering experiments, and the ThT ﬂuo-
rescence measurements indicates that these initial aggregates
contain signiﬁcant amounts of intermolecular b-sheet (see
Figs. 2 and 3). The presence of a measurable ThT intensity
(above background levels) in the plateau region also suggests
that repeat b-sheet folds are present in these aggregates (24).
However, AFM images of the samples did not show the
presence of any ﬁbrils in the bulk solution or on the PS
surfaces during this initial period of b-sheet growth (see
inset, Fig. 2). Only small, less well-deﬁned aggregates were
observed with the AFM during this time period in both the
bulk solution and PS surface experiments. The presence of
nanoscale nonﬁbrillar aggregates has also been reported for
other small polypeptides (25,26) during studies of ﬁbril
formation. We note at this point that great care must be
taken in interpreting the AFM images shown in Fig. 2. The
drying of protein solutions is often unreliable and can lead to
different quantities of ﬁbrils and other aggregates being
FIGURE 2 Kinetics of b-sheet formation during the aggregation of
bovine pancreatic insulin. Data are shown for insulin aggregating in bulk
solution (d) and near a PS surface (D). In both cases, the area of the b-sheet
peak was divided by the total area of the amide II region collected at each
time. The inset shows a plot of the variation in the area of the amide II region
with time. In both cases, the area of this peak was divided by the initial area
of this region. All data were collected at a temperature of 60C and at pH 1.
The AFM images shown as insets were collected using a scan area of
5 mm 3 5 mm and show typical images of the observed aggregate morpho-
logies at the times indicated by the solid arrows.
FIGURE 3 Dynamic light scattering (h, left axis) and ThT ﬂuorescence
studies (:, right axis) of the aggregation on bovine pancreatic insulin. All
data were collected at a temperature of 60C and at pH 1.
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observed on what should be identical samples. However, if
sufﬁcient AFM images are collected, this technique can be
used to conﬁrm the presence or absence of ﬁbrils and to
make qualitative comparisons between the morphologies of
the aggregates that are formed.
The second, more rapid region of b-sheet formation was
attributed to the growth of ﬁbrils and was mirrored in both
the ThT ﬂuorescence and dynamic light-scattering studies.
The presence of ﬁbrils was conﬁrmed by collecting AFM
images of both PS surface-adsorbed and bulk-solution
protein (see inset, Fig. 2). The onset of ﬁbril formation was
found to occur earlier at PS/water interfaces than in bulk
solution, and the initial rates of ﬁbril growth/b-sheet for-
mation were found to be slower on the PS surfaces (as de-
termined from the slopes of the curves in the main panel of
Fig. 2). Qualitatively this indicates that ﬁbril nucleus for-
mation occurs faster on the PS surfaces than in bulk solution.
The reduction in the growth rates associated with the b-sheet
formation kinetics on the PS surfaces also indicates that the
presence of the PS surface hinders the growth of insulin
ﬁbrils.
A consideration of the kinetics of the changes in the area
of the amide II peak for the PS surface experiments (see
inset, Fig. 2) indicates that a layer of protein was rapidly
(within 15 s) adsorbed at the PS/water interface after the
injection of BPI into the ATR sample cell. After this initial
deposition, the amount of protein at the interface did not
increase signiﬁcantly until the onset of ﬁbril growth. At this
point, the amide II peak area increases along with the area of
the b-sheet peak. This is likely to be caused by a com-
bination of effects related to the addition of protein molecules
to surface-nucleated ﬁbrils (elongation) and the adsorption of
bulk-nucleated ﬁbrils on the PS surfaces (deposition).
However, distinguishing between these two processes is
not possible in the context of these experiments.
The ﬁnal saturation point in the b-sheet absorbance
kinetics was found to be similar for the PS surface and bulk
solution at each temperature studied. At the point where the
b-sheet kinetics saturated, the BPI solutions were found to
form a viscous opaque gel. Cryo-scanning electron micros-
copy of these gels revealed that they contain a large tangled
network of mature ﬁbrils (data not shown).
In the bulk solution IR studies, the absorbance changes
(A(t)) measured in the ﬁnal stage of the b-sheet growth
kinetics were found to follow an exponential rise of the form
AðtÞ ¼ Ap1 ðAo  ApÞ 1 exp t  tn
ta
  
; (1)
where Ap and Ao are the absorbance values in the ﬁrst plateau
region and at saturation, respectively. The quantities tn and
1/ta represent the ﬁbril nucleation/lag time and growth rate,
respectively. We note that care has to be taken in interpreting
the parameter ta because this quantity contains information
about both the elongation of existing ﬁbrils and the nucle-
ation of new ﬁbrils that occurs during the late stages of
b-sheet growth. Distinguishing between these two processes
is not possible in the context of these experiments. However,
tn is the time when ﬁbrils are initially observed to form and
represents a measure of the true nucleation/lag times in the
system.
Fig. 4 shows semilogarithmic plots of the reduced
absorbance (1  A(t)/Ao) versus time for bulk solution
protein (panel a) and PS surface-adsorbed protein (panel b)
at a range of temperatures between 60C and 80C. In the
ATR studies, multiple measurements were made at temper-
atures close to 65C, 70C, and 75C to check reproduci-
bility. However, the temperatures given in the caption in Fig.
4 are approximate values derived from the setting on the
temperature controller and are not the actual temperature
values. The actual temperature varied by as much as 61C
from the temperature controller setting. The differences
between the true measured temperature values and the
approximate set-point values quoted in the ﬁgure caption
FIGURE 4 Semilogarithmic plots of the reduced b-sheet absorbance (1
A(t)/Ao) of bovine pancreatic insulin versus time. Data are shown for the
bulk aggregation kinetics (top panel ) and for aggregation at a PS surface
(bottom panel ). In both cases data were collected at pH 1 and at temperatures
close to 60C (s), 65C (h), 70C (D), 75C (d), and 80C (n),
respectively. All temperature values were measured with an uncertainty of
61C. The solid black lines show the ﬁts used to determine the aggregation
rates (see text). The horizontal dashed lines mark the position of the plateau
region (A ¼ Ap) that was used in determining the nucleation/lag time for
ﬁbril formation (see text).
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account for the differences in kinetics that are observed
between what should be identical data sets in the PS surface
data shown in Fig. 4.
The experimental scatter that is observed in the bottom
panel of Fig. 4 in the late stages of b-sheet formation is an
artefact that occurs because the measured absorbance
approaches the value A0, and the corresponding value of
1  A/A0 approaches the level of noise in the experiments.
Taking the natural logarithm of the reduced absorbance
therefore leads to this noise becoming clearly visible in the
data as the value of A approaches its ﬁnal value, A0.
According to Eq. 1, plots of loge (1  A(t)/Ao) versus time
similar to those shown in Fig. 4 should produce a straight
line in the region corresponding to ﬁbril growth with a slope
that is equal to the aggregation rate, 1/ta. As can be seen in
the top panel of this ﬁgure, this region is accurately ﬁtted by
a single straight line for the bulk data. In the case of the PS-
adsorbed protein, two such linear regions exist (Fig. 4,
bottom panel). The ﬁrst slope is shallower than the slope
observed for the bulk solution studies and occurs at earlier
times. This slope was attributed to the formation of ﬁbrils by
insulin molecules that interact directly with the PS surface.
AFM images of the PS surfaces taken during the period
corresponding to the initial slope in the second stage of
b-sheet growth showed evidence of a number of BPI ﬁbrils
at times when no bulk solution ﬁbrils were observed (see
inset, Fig. 2). The second slope in the PS surface data started
at similar times and had comparable (but not identical) slopes
to those observed in the bulk solution studies. This region
was attributed to the bulk component of the signal acquired
in the ATR experiments performed on the PS surfaces. These
data are expected to show some features of the bulk solu-
tion response of the protein because the evanescent ﬁeld
used to probe the PS/water interface extends ;1 mm into
the solution. Although ATR is predominantly surface sensi-
tive, the penetration depth of the evanescent ﬁeld will ex-
tend beyond the thickness of any adsorbed protein layers
and, as a result, will be sensitive to insulin molecules in bulk
solution.
In each case, the slope of the linear regions was used to
determine the aggregation/b-sheet growth rates (1/ta) asso-
ciated with the formation of BPI ﬁbrils. The natural log-
arithm of the aggregation rate was then plotted against the
inverse of temperature to produce Arrhenius plots for both
bulk solution data and the PS surface data (see top panel,
Fig. 5). The PS surface data shown in Fig. 5 are split into two
components. The ﬁrst corresponds to the bulk component of
the aggregation measured in the ATR experiments, and the
second corresponds to the true PS surface component of the
data. This ﬁgure shows that the aggregation rates obtained
from Fig. 4 are faster in bulk solution than on the PS surface.
Moreover, the bulk solution aggregation rates appear to be
faster than the bulk component of the aggregation kinetics
measured using the ATR cell. This is discussed in more
detail below.
The linear ﬁts to the aggregation rate data shown in Fig. 5
were used to determine the energy barriers associated with
ﬁbril formation according to the Arrhenius equation
loge
1
ta
 
¼ loge
1
ta;o
 
 Ea
RT
; (2)
where Ea is the energy barrier associated with ﬁbril for-
mation (Jmol1), R is the molar gas constant (Jmol1K1),
T is the temperature (K), and 1/ta,o is a characteristic attempt
frequency associated with ﬁbril growth (s1). At this point
we note that the values of 1/ta shown in Fig. 5 represent an
average measure of the growth rates of all the aggregates in
the system and not the individual ﬁbril elongation rates.
However, the amount of b-sheet formed in the system is
expected to be directly proportional to the length of the ﬁbrils
formed. This means that under a given set of solution
conditions, the aggregation/b-sheet formation rates shown in
this ﬁgure will be related to the average ﬁbril elongation rate
by a simple numerical factor. However, the fact that Ea is
derived from the temperature dependence of these scaled
FIGURE 5 Arrhenius plots of the aggregation/ﬁbrillization rates (top
panel ) and effective nucleation rates (bottom panel) of BPI at pH 1. Data are
shown for bulk solution (s), the PS surface data (:), and the bulk com-
ponent of the PS surface data (D, see text). The solid lines represent ﬁts to the
form of Eq. 2.
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aggregation rates means that Ea represents a measure of the
true energy barrier for ﬁbril growth.
The values obtained for the energy barrier, Ea from Fig. 5
are summarized in Table 1. The values shown are comparable
to values that have been reported for insulin and proteins/
peptides of comparable size under similar solution conditions
(25,27). Table 1 clearly shows that the energy barrier
associated with the growth of ﬁbrils on PS surfaces is larger
than the corresponding barrier associated with bulk solution
ﬁbril growth, within the limits of experimental uncertainty.
This suggests that it is more difﬁcult for ﬁbrils to grow on
hydrophobic PS surfaces than in bulk solution. The reason for
this could be interpreted in a number of ways. The energy
barriers presented in Table 1 represent a composite barrier that
describes the change from the native solution state of the
protein to an aggregated state. This energy barrier is therefore
likely to include separate energy contributions related to
differences in protein concentration and the colloidal and
conformational stability of the protein molecules (15). The
concentration and conformation of protein molecules ad-
sorbed at the hydrophobic polymer surface and at the end of
adsorbed ﬁbrils are likely to differ from similar molecules in
solution. These factors would be expected to alter the prob-
abilities associated with the collision and sticking of two
neighboring protein molecules. They would also affect the
folding pathways associated with the attachment of protein
molecules to the end of the growing ﬁbril andwould inﬂuence
the corresponding contributions to the measured free energy
barrier. The presence of charged protein molecules close to a
dielectric material such as PS could also induce polarization
charges in the polymer ﬁlms that would alter the charge
distribution around the tip of an adsorbed growing ﬁbril. All
of these factors could contribute to the observed differences
in the aggregate/ﬁbril growth barrier, but they are difﬁcult
to quantify in the context of this study.
It is also noteworthy that the energy barrier derived from
the bulk component of the aggregation measured in the ATR
experiments is larger than the energy barrier determined
from bulk solution IR transmission measurements. As shown
in Fig. 5 and Table 1, the aggregation rates and the energy
barrier determined from the bulk component of the PS
surface data fall in between those obtained for the ‘‘true’’
measured bulk and surface values. To determine the cause of
this apparent discrepancy, a simple experiment was per-
formed in which BPI was absorbed at a PS surface and the
excess bulk solution protein was then ﬂushed from the cell
using the D2O-based stock solutions. Measurement of the
ATR spectra before and after ﬂushing the cell showed that
the measured absorbance from surface-adsorbed protein re-
presented ;50% of the total measured signal. This accounts
for the fact that the energy barrier and aggregation rates for
the bulk component of the PS surface data appear to be
weighted averages of the corresponding bulk and surface
values.
In addition to being used to determine the aggregation
rates, the plots shown in Fig. 4 were also used to estimate the
characteristic nucleation or lag times, tn, for the onset of
ﬁbril growth. This was done by determining the point of
intersection of the ﬁbril growth rate ﬁt lines with the
horizontal dashed lines used to deﬁne the plateau region in
the kinetics (see Fig. 4). These nucleation times were then
used to deﬁne an effective nucleation rate, 1/tn. The resulting
nucleation rates are plotted on an Arrhenius diagram in the
bottom panel of Fig. 5. The plots shown in Fig. 5 were used
to extract the energy barriers (En) and attempt frequencies
1/tn,o associated with the onset of ﬁbril formation, using a
similar procedure to that described for the ﬁbril growth rates.
The values of (En) that were obtained for the bulk solution
and PS surface studies are summarized in Table 1. The
energy barriers to ﬁbril nucleation shown in Table 1 are
comparable to (but smaller than) those observed for the
aggregation of peptide chains of a similar size (28). As
shown in Table 1, the nucleation barriers in all three cases are
the same within the limits of experimental uncertainty.
Initially, this may seem counterintuitive given that there are
clear observable differences in the measured nucleation rates
for the bulk and PS surface data sets (see Figs. 4 and 5). The
presence of a hydrophobic interface might also be expected
to cause the protein to unfold to expose more hydrophobic
residues in the core of the insulin molecules to the PS
surface. This would be expected to result in both a decrease
in the enthalpy of interaction and an increase in the con-
formational entropy of the protein molecules (1) adsorbed at
the PS/water interface. These combined factors would act to
reduce the free energy barrier associated with the unfolding
and subsequent aggregation of the protein. However, it is
worth considering that the conformations adopted by the
insulin molecules at the PS surfaces would not necessarily
correspond to viable ﬁbril-forming intermediate states. As a
result, a surface-unfolded insulin molecule could experience
a local conformational free energy barrier that is similar to
that of a protein in bulk solution. The energy barrier as-
sociated with ﬁbril nucleus formation would therefore not
necessarily be altered signiﬁcantly by forcing the protein to
unfold at an interface.
Despite the fact that the ﬁbril nucleation barriers are not
signiﬁcantly changed, Fig. 5 shows that the rates associated
with the formation of ﬁbril nuclei are increased by the
presence of the PS surface. If the energy barriers associated
with ﬁbril nucleus formation remain unchanged, this sug-
gests that the characteristic attempt frequencies associated
with nucleus formation must be larger (see Eq. 2). One
possible reason for this could be related to differences in the
TABLE 1 Energy barriers for ﬁbril nucleation and growth
Energy barrier (kJmol1) Nucleation Fibril growth
Bulk 117 6 2 72 6 10
Polystyrene (bulk component) 111 6 6 97 6 3
Polystyrene (surface component) 119 6 11 120 6 14
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concentration of protein molecules in the bulk and on the
PS surfaces. In the ATR experiments, the PS surfaces were
rapidly coated (within 15 s) with a surface excess of insulin.
This resulted in a larger local protein concentration at the
surface than in bulk solution. The localization of a ‘‘dense’’
layer of protein at the PS surface would therefore increase the
probability of two insulin molecules coming into contact and
would result in a corresponding increase in the attempt
frequency associated with the formation of viable ﬁbril
nuclei.
Regardless of the mechanism that is responsible for the
accelerated formation of ﬁbril nuclei, this experimental
observation has some potentially far-reaching implications
with regard to the toxicology of high-surface-area nanoscale
materials. Fibril precursors have recently been implicated as
being the toxic species in a number of amyloid-related dis-
eases (29). As these experiments show, the presence of arti-
ﬁcial surfaces such as the model PS surfaces studied causes
the more rapid formation of these ﬁbril precursors or nuclei.
This means that great care must be taken to assess the full
toxicological impact of new nanoscale diagnostic and thera-
peutic agents before they are released on to the market.
It is not clear if the smaller aggregates formed in the initial
stages of aggregation play a role in the formation of ﬁbrils. If
the formation of ﬁbril nuclei was inﬂuenced by the presence
of these smaller aggregates, then we would expect to observe
a correspondence between the temperature dependence of the
ﬁbril nucleation rates and that of the rates associated with
the formation of these smaller aggregates. A comparison of
the rates associated with b-sheet formation during small
aggregate formation (see insets, Fig. 4) shows that there are
factors of 4 and 10 difference between the lowest and highest
temperatures studied for the bulk solution and PS surface
experiments, respectively. The difference in the ﬁbril nucle-
ation rates at the two temperature extremes studied corre-
sponds to a factor of 10 in the values determined from Fig. 5.
This would seem to suggest that there is some correlation
between the formation of these smaller aggregates and the
onset of ﬁbril nucleation. However, the data presented in the
insets of Fig. 4 contain signiﬁcant amounts of scatter, and
more detailed analysis of these results would be unreason-
able. More detailed studies of the early-stage kinetics of
formation of these small aggregates would be required to
determine if they are linked to ﬁbril nucleation.
The timescales associated with both the nucleation and
growth of ﬁbrils shown in Fig. 4 are similar to those reported
for insulin under similar solution conditions (30). We note
that the study performed by Krebs and co-workers (30) deals
mainly with the study of amyloid spherulites of insulin and
not directly with insulin ﬁbrils. However, because the for-
mation of amyloid spherulites involves the growth of ﬁbrillar
material around an ‘‘amorphous’’ protein core, we would
expect the timescales associated with the formation of amy-
loid spherulites to be comparable to those measured in ﬁbril
growth studies performed under similar solution conditions.
It is also worth remarking that no amyloid spherulites were
observed during the experiments described in the study
presented here. Crossed-polarizer light microscopy, SEM,
and AFM were used to look for the presence of spherulites.
The characteristic micrometer-sized birefringent structures
that are associated with the formation of amyloid spherulites
were not observed in any of the samples studied and could be
observed only when foreign nucleating agents (such as small
colloidal particles) or undissolved protein were added to the
solutions.
At the temperatures studied, the ﬁbril nucleation and
growth rates (see Fig. 5) have values that vary between
;1 3 104 s1 and ;2 3 102 s1. The characteristic time
associated with the folding of a b-sheet ‘‘hairpin’’ structure
has been reported for peptide chains that are comparable in
size to an insulin molecule (25,31). These studies showed
that the time associated with the folding of a b-hairpin
structure for an isolated peptide chain is of the order of ;20
ms, but the timescales associated with formation of inter-
molecular b-sheet structures during aggregation can be
signiﬁcantly longer (;2 ms). These timescales correspond to
rates of ;5 3 104 s1 and ;500 s1, respectively. The
aggregation/ﬁbril growth rates measured in this study are
up to 108 times smaller than the rates associated with the
formation of intermolecular b-sheet. This suggests that
conformational changes alone are not sufﬁcient to account
for the aggregation rates measured here and that the growth
rates of insulin ﬁbrils at the pH values and salt concentrations
studied are also mediated by other factors such as colloidal
stability (15). This is not surprising when consideration is
given to the fact that the isoelectric point of insulin occurs at
5.3 (32) and the pI of the solutions studied is 1. Under such
solution conditions, each insulin molecule would be ex-
pected to carry a net charge of;9.63 1019 C (16e) (1,17).
This would result in the formation of charged double layers
(33) around the insulin molecules that would repel neigh-
boring proteins and reduce the associated aggregation rates.
In each case the characteristic attempt frequency (1/to)
was typically found to lie in the range 1012–1014 s1. This is
comparable to the high-temperature relaxation rate of a
simple liquid (;1013 s1) and represents a reasonable upper
bound for the attempt frequency (25). This is because both
ﬁbril nucleation and growth are expected to involve the
translation of molecules from the surrounding solution envi-
ronment to the tip of the growing ﬁbril. However, a more
detailed analysis of the attempt frequencies would be unrea-
listic because these values are obtained by extrapolating the
aggregate growth rates by over 10 orders of magnitude.
CONCLUSIONS
A method has been presented for determining the rates of
aggregation and the energy barriers associated with insulin
ﬁbril nucleation and growth in bulk solution and at model PS
surfaces. These experiments showed that the presence of
2150 Smith et al.
Biophysical Journal 93(6) 2143–2151
hydrophobic PS surfaces promoted the nucleation of ﬁbrils
but did not affect the size of the ﬁbril nucleation barrier
(within error). The PS interface did, however, increase the
energy barrier associated with the growth/elongation of insu-
lin ﬁbrils. These observations were brieﬂy explained in terms
of the differences in conformational and colloidal stability of
the proteins in solution and on surfaces as well as differences
associated with protein concentration effects and the mobility
of the insulin molecules. The method described in this work
involves the use of well-established IR spectroscopy–based
protein characterization methods, and we anticipate that this
technique could also be used to study aggregation in other
protein/surface systems.
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